PRDX4 and Its Roles in Various Cancers

Area of Science:

• Cellular Biology
• Biochemistry
• Oncology

Background:

• Reactive oxygen species (ROS) are vital for cell survival, regulating metabolism and signal transduction.
• An imbalance between oxidants and antioxidants leads to oxidative stress, impacting stem cell, cancer cell, and cancer stem cell survival and proliferation.
• Peroxiredoxin 4 (PRDX4), an endoplasmic reticulum-resident antioxidant, modulates hydrogen peroxide metabolism, influencing cell survival through redox balance, protein folding, and ROS signaling.

Purpose of the Study:

• To review the physiological functions of Peroxiredoxin 4.
• To summarize recent research on mammalian Peroxiredoxin 4 in cancer.
• To evaluate Peroxiredoxin 4 as a potential therapeutic target for various cancers.

Main Methods:

• Literature review of physiological roles of Peroxiredoxin 4.
• Analysis of studies investigating Peroxiredoxin 4 expression in cancer.
• Examination of research linking Peroxiredoxin 4 to cancer progression and therapeutic resistance.

Main Results:

• Peroxiredoxin 4 overexpression is observed in multiple cancers, including breast, prostate, ovarian, colorectal, and lung cancer.
• Peroxiredoxin 4 contributes to tumorigenesis, therapeutic resistance, metastasis, and tumor recurrence.
• PRDX4's role in redox balance and cellular signaling is critical for cancer cell survival and proliferation.

Conclusions:

• Peroxiredoxin 4 plays a significant role in cancer development and progression.
• Peroxiredoxin 4 is implicated in key cancer hallmarks such as proliferation, resistance to therapy, and metastasis.
• Peroxiredoxin 4 demonstrates potential as a novel therapeutic target for multiple types of cancer.